CN104225153A - Traditional Chinese medicine for treating metaplastic spondylitis - Google Patents
Traditional Chinese medicine for treating metaplastic spondylitis Download PDFInfo
- Publication number
- CN104225153A CN104225153A CN201410127635.8A CN201410127635A CN104225153A CN 104225153 A CN104225153 A CN 104225153A CN 201410127635 A CN201410127635 A CN 201410127635A CN 104225153 A CN104225153 A CN 104225153A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- grams
- chinese medicine
- spondylitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine for treating metaplastic spondylitis, which is characterized by being prepared from the following medicinal materials in parts by weight: 15 parts of angelica pubescens, 20 parts of herba taxilli, 15 parts of gentiana macrophylla, 15 parts of saposhnicovia divaricata, 5 parts of asarum, 15 parts of rhizoma chuanxiong, 20 parts of angelica sinensis, 20 parts of radix rehmanniae preparata, 20 parts of white peony roots, 15 parts of cassia twig, 20 parts of poria cocos, 20 parts of eucommia ulmoides, 20 parts of achyranthes bidentata, 20 parts of radix codonopsis, 15 parts of yam, 15 parts of cornus officinalis, 15 parts of antler gum, 15 parts of rhizoma cibotii, 6 parts of cinnamon, 6 parts of prepared monkshood, 15 parts of drynaria total flavonoids, 15 parts of dipsacus asperoids, 15 parts of astragalus, 15 parts of clematis chinensis, 6 parts of sinapis alba, 15 parts of ligustrum lucidum ait, 10 parts of scrophulariae, 15 parts of tortoise plastron, 15 parts of fructus lycii, 15 parts of radix moridae officinalls, and 5 parts of radix glycyrrhizae. Clinical experiments show that the traditional Chinese medicine disclosed by the invention can safely and effectively treat hyperplastic spondylitis.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine for the treatment of hyperplastic spondylitis.
Background technology
Hyperplastic spondylitis is a kind of commonly encountered diseases, frequently-occurring disease, is generally invaded by deficiency of the liver and kindey, exopathogen visitor, obstruction of collaterals by blood stasis causes.Primary disease is a kind of arthroxerosis, therefore the initial stage is general without clinical symptoms, and small number of patients can occur that chronic low back is ached, deadlock etc. is sent out in activity.Late period, the formation of bony spur, can produce the series of symptoms based on low back pain: dull pain, increases the weight of time tired or cloudy, and daystart WA waist is stiff along with the development of the state of an illness.Hyperplastic spondylitis affects the able-bodied important diseases of people.Treatment not in time, lack of standardization, hyperplastic spondylitis can cause even entail dangers to life of paralysing.Current medicine is cured the symptoms, not the disease, and conventional has dependency and side effect.Therefore the Chinese medicine researching and developing a kind of safe and effective treatment hyperplastic spondylitis is very with practical value.
Summary of the invention
The problem to be solved in the present invention is: provide a kind of Chinese medicine for the treatment of hyperplastic spondylitis, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing hyperplastic spondylitis.
In order to solve the problems of the technologies described above, the present invention by the following technical solutions:
Treat a Chinese medicine for hyperplastic spondylitis, it is characterized in that, it is prepared from by the medical material of following parts by weight proportioning:
Radix Angelicae Pubescentis 15 parts, Herba Taxilli 20 parts, Radix Gentianae Macrophyllae 15 parts, Radix Saposhnikoviae 15 parts, Herba Asari 5 parts, Rhizoma Chuanxiong 15 parts, Radix Angelicae Sinensis 20 parts, 20 parts, Radix Rehmanniae Preparata, the Radix Paeoniae Alba 20 parts, Ramulus Cinnamomi 15 parts, 20 parts, Poria, the Cortex Eucommiae 20 parts, Radix Achyranthis Bidentatae 20 parts, Radix Codonopsis 20 parts, Rhizoma Dioscoreae 15 parts, Fructus Corni 15 parts, Colla cornus cervi 15 parts, Rhizoma Cibotii 15 parts, Cortex Cinnamomi 6 parts, gun additioner 6 parts, Rhizoma Drynariae 15 parts, Radix Dipsaci 15 parts, the Radix Astragali 15 parts, Radix Clematidis 15 parts, Semen Sinapis Albae 6 parts, Fructus Ligustri Lucidi 15 parts, Radix Scrophulariae 10 parts, Carapax et Plastrum Testudinis 15 parts, Fructus Lycii 15 parts, Radix Morindae Officinalis 15 parts, 5 parts, Radix Glycyrrhizae.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, general material
Inventor collects the out-patient that 100 examples suffer from hyperplastic spondylitis altogether, is divided at random: treatment group 50 example, matched group 50 example.The data such as two groups of sexes, age, state of an illness there are no significant difference, has comparability.
2, test method
The oral common anti-inflammation analgesic of matched group, uses to specifications.1 month course for the treatment of.
The capsule that the oral the present invention for the treatment of group obtains according to specific embodiment 1, every bu is taken for 2 times sooner or later.1 month course for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
(1) fully recover: clinical symptoms and sign disappear completely or substantially disappear;
(2) effective: clinical symptoms and sign major part take a turn for the better or be clearly better;
(3) invalid; Clinical symptoms and sign are all not improved, symptom as front, DeGrain.
3.2 treatment statistical results are in table 1.
Table 1 liang group comparitive study
| Group | Case number | Recovery from illness | Effective | Invalid | Untoward reaction | Total effective rate % |
| Treatment group | 50 | 28 | 20 | 2 | 0（0%） | 96% |
| Matched group | 50 | 5 | 15 | 30 | 0（0%） | 40% |
Visible, the medicine that the preferred embodiment for the present invention obtains can treat hyperplastic spondylitis safely and effectively.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Specific embodiment 1
Take Radix Angelicae Pubescentis 15 grams, Herba Taxilli 20 grams, Radix Gentianae Macrophyllae 15 grams, Radix Saposhnikoviae 15 grams, Herba Asari 5 grams, Rhizoma Chuanxiong 15 grams, Radix Angelicae Sinensis 20 grams, 20 grams, Radix Rehmanniae Preparata, the Radix Paeoniae Alba 20 grams, Ramulus Cinnamomi 15 grams, 20 grams, Poria, the Cortex Eucommiae 20 grams, Radix Achyranthis Bidentatae 20 grams, Radix Codonopsis 20 grams, Rhizoma Dioscoreae 15 grams, Fructus Corni 15 grams, Colla cornus cervi 15 grams, Rhizoma Cibotii 15 grams, Cortex Cinnamomi 6 grams, gun additioner 6 grams, Rhizoma Drynariae 15 grams, Radix Dipsaci 15 grams, the Radix Astragali 15 grams, Radix Clematidis 15 grams, Semen Sinapis Albae 6 grams, Fructus Ligustri Lucidi 15 grams, Radix Scrophulariae 10 grams, Carapax et Plastrum Testudinis 15 grams, Fructus Lycii 15 grams, Radix Morindae Officinalis 15 grams, 5 grams, Radix Glycyrrhizae.Add 10 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, load in capsulae vacuus, the capsule of adult normal's one day consumption must be met.
Be used for the treatment of hyperplastic spondylitis.Oral, every bu is taken for twice sooner or later.
Specific embodiment 2
Take Radix Angelicae Pubescentis 15 grams, Herba Taxilli 20 grams, Radix Gentianae Macrophyllae 15 grams, Radix Saposhnikoviae 15 grams, Herba Asari 5 grams, Rhizoma Chuanxiong 15 grams, Radix Angelicae Sinensis 20 grams, 20 grams, Radix Rehmanniae Preparata, the Radix Paeoniae Alba 20 grams, Ramulus Cinnamomi 15 grams, 20 grams, Poria, the Cortex Eucommiae 20 grams, Radix Achyranthis Bidentatae 20 grams, Radix Codonopsis 20 grams, Rhizoma Dioscoreae 15 grams, Fructus Corni 15 grams, Colla cornus cervi 15 grams, Rhizoma Cibotii 15 grams, Cortex Cinnamomi 6 grams, gun additioner 6 grams, Rhizoma Drynariae 15 grams, Radix Dipsaci 15 grams, the Radix Astragali 15 grams, Radix Clematidis 15 grams, Semen Sinapis Albae 6 grams, Fructus Ligustri Lucidi 15 grams, Radix Scrophulariae 10 grams, Carapax et Plastrum Testudinis 15 grams, Fructus Lycii 15 grams, Radix Morindae Officinalis 15 grams, 5 grams, Radix Glycyrrhizae.Add 12 times of water gagings, decoct 2 hours, filter; Filtering residue adds 10 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of hyperplastic spondylitis.Oral, every bu is taken for twice sooner or later.
Specific embodiment 3
Take Radix Angelicae Pubescentis 15 grams, Herba Taxilli 20 grams, Radix Gentianae Macrophyllae 15 grams, Radix Saposhnikoviae 15 grams, Herba Asari 5 grams, Rhizoma Chuanxiong 15 grams, Radix Angelicae Sinensis 20 grams, 20 grams, Radix Rehmanniae Preparata, the Radix Paeoniae Alba 20 grams, Ramulus Cinnamomi 15 grams, 20 grams, Poria, the Cortex Eucommiae 20 grams, Radix Achyranthis Bidentatae 20 grams, Radix Codonopsis 20 grams, Rhizoma Dioscoreae 15 grams, Fructus Corni 15 grams, Colla cornus cervi 15 grams, Rhizoma Cibotii 15 grams, Cortex Cinnamomi 6 grams, gun additioner 6 grams, Rhizoma Drynariae 15 grams, Radix Dipsaci 15 grams, the Radix Astragali 15 grams, Radix Clematidis 15 grams, Semen Sinapis Albae 6 grams, Fructus Ligustri Lucidi 15 grams, Radix Scrophulariae 10 grams, Carapax et Plastrum Testudinis 15 grams, Fructus Lycii 15 grams, Radix Morindae Officinalis 15 grams, 5 grams, Radix Glycyrrhizae.Add 8 times of water gagings, decoct 2 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, then add appropriate dextrin and correctives, granulate according to this area common process, packaging, must meet the granule of adult normal's one day consumption.
Be used for the treatment of hyperplastic spondylitis.Oral, every bu is taken for twice sooner or later.
Facts have proved through a large amount of clinical treatments, the present invention treats the Chinese medicine of hyperplastic spondylitis, belongs to pure Chinese medicinal preparation, little to human body toxicity, side effect, and to treating, hyperplastic spondylitis has reliably, safety, significant therapeutic effect.
Claims (1)
1. treat the Chinese medicine of hyperplastic spondylitis for one kind, it is characterized in that, it is prepared from by the medical material of following parts by weight proportioning: Radix Angelicae Pubescentis 15 parts, Herba Taxilli 20 parts, Radix Gentianae Macrophyllae 15 parts, Radix Saposhnikoviae 15 parts, Herba Asari 5 parts, Rhizoma Chuanxiong 15 parts, Radix Angelicae Sinensis 20 parts, 20 parts, Radix Rehmanniae Preparata, the Radix Paeoniae Alba 20 parts, Ramulus Cinnamomi 15 parts, 20 parts, Poria, the Cortex Eucommiae 20 parts, Radix Achyranthis Bidentatae 20 parts, Radix Codonopsis 20 parts, Rhizoma Dioscoreae 15 parts, Fructus Corni 15 parts, Colla cornus cervi 15 parts, Rhizoma Cibotii 15 parts, Cortex Cinnamomi 6 parts, gun additioner 6 parts, Rhizoma Drynariae 15 parts, Radix Dipsaci 15 parts, the Radix Astragali 15 parts, Radix Clematidis 15 parts, Semen Sinapis Albae 6 parts, Fructus Ligustri Lucidi 15 parts, Radix Scrophulariae 10 parts, Carapax et Plastrum Testudinis 15 parts, Fructus Lycii 15 parts, Radix Morindae Officinalis 15 parts, 5 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410127635.8A CN104225153A (en) | 2014-03-31 | 2014-03-31 | Traditional Chinese medicine for treating metaplastic spondylitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410127635.8A CN104225153A (en) | 2014-03-31 | 2014-03-31 | Traditional Chinese medicine for treating metaplastic spondylitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104225153A true CN104225153A (en) | 2014-12-24 |
Family
ID=52214629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410127635.8A Pending CN104225153A (en) | 2014-03-31 | 2014-03-31 | Traditional Chinese medicine for treating metaplastic spondylitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104225153A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250530A (en) * | 2015-10-26 | 2016-01-20 | 张�杰 | Bony spur eliminating powder |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102018821A (en) * | 2010-11-19 | 2011-04-20 | 王丽华 | Chinese medicament for treating hypertrophic rachitis |
| CN103054966A (en) * | 2012-12-23 | 2013-04-24 | 徐化利 | Traditional Chinese medicine formula for treating proliferative spondylitis |
-
2014
- 2014-03-31 CN CN201410127635.8A patent/CN104225153A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102018821A (en) * | 2010-11-19 | 2011-04-20 | 王丽华 | Chinese medicament for treating hypertrophic rachitis |
| CN103054966A (en) * | 2012-12-23 | 2013-04-24 | 徐化利 | Traditional Chinese medicine formula for treating proliferative spondylitis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250530A (en) * | 2015-10-26 | 2016-01-20 | 张�杰 | Bony spur eliminating powder |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102836339B (en) | Medicine for treating diabetic nephropathy | |
| CN104225536A (en) | Traditional Chinese medicine for treating stomach ulcer and duodenal ulcer | |
| CN104474371A (en) | Traditional Chinese medicine for treating impotence | |
| CN103990093A (en) | Traditional Chinese medicine for treating obstructive emphysema caused by spleen-deficiency and phlegm-turbid stagnation | |
| CN104173986A (en) | Traditional Chinese medicine for treating heart failure | |
| CN104147551A (en) | Traditional Chinese medicine for treating polycystic ovarian syndrome | |
| CN103055298A (en) | Traditional Chinese medicine for treating rheumatoid cold arthralgia | |
| CN104127747A (en) | Traditional Chinese medicament for treating suppurative tonsillitis | |
| CN104173834A (en) | Traditional Chinese medicine for treating meniere disease | |
| CN104189847A (en) | Traditional Chinese medicine for treating tuberculous exadative pleurisy | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN104225153A (en) | Traditional Chinese medicine for treating metaplastic spondylitis | |
| CN102240342A (en) | Traditional Chinese medicine for treating viral hepatitis A | |
| CN104127632A (en) | Traditional Chinese medicine for curing lumbar spinal stenosis | |
| CN104173878A (en) | Traditional Chinese medicine for treating acute glomerulonephritis | |
| CN102240338B (en) | Traditional Chinese preparation for treating cerebral hemiplegia | |
| CN104083749A (en) | Traditional Chinese medicine for treating polycystic ovarian syndrome | |
| CN104225474A (en) | Traditional Chinese medicine for treating chronic lung abscess | |
| CN102847066B (en) | Chinese herbal medicine for treating lumbocrural pains | |
| CN104189700A (en) | Traditional Chinese medicine for treating senile dementia | |
| CN103007236B (en) | Chinese medicinal composition for treating ankylosing spondylitis | |
| CN104013718A (en) | Field thistle decoction traditional Chinese medicine preparation | |
| CN1342478A (en) | Medical wine for treating rheumatism | |
| CN105816602A (en) | Traditional Chinese medicine composition for treating chronic pain in waist and lower extremities | |
| CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141224 |
|
| RJ01 | Rejection of invention patent application after publication |